Screener
Capricor Therapeutics CAPR Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Capricor Therapeutics’s reported figures.
Based on trailing twelve months.
The source filing: Capricor Therapeutics’s 10-Q, filed November 10, 2025. Open the filing →
- Filed
- Nov 10, 2025
- Fiscal quarter
- Q3 FY2025
- Calendar quarter
- Q3 2025
- Accession
- 0001104659-25-109298
FAQ
- What is Capricor Therapeutics's free cash flow margin?
- Capricor Therapeutics (CAPR) reported free cash flow margin of -563.9% in Q3 2025.
- How has Capricor Therapeutics's free cash flow margin changed year-over-year?
- Capricor Therapeutics's free cash flow margin decreased by 244.4% year-over-year, from -163.7% to -563.9%.
- What is the long-term trend for Capricor Therapeutics's free cash flow margin?
- Over 2 years (2020 to 2024), Capricor Therapeutics's free cash flow margin has grown at a -76.7% compound annual growth rate (CAGR), from -3,417.4% to -184.8%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.
Ask your AI about Capricor Therapeutics's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude